Zastosowanie naringeniny i naringiny jako inhibitorów dla ścieżki sygnałowej transformującego czynnika wzrostu BETA1

• 收藏
• 分享

专利权人:

Henan Topfond Pharmaceutical Co., Ltd.;The Institute of Biophysics Chinese Academy of Sciences

发明人:

LIANG, WEI,DU, GANGJUN,ZHANG, HONGYAN,JIN, LINGTAO,LV, HEPING,WANG, WEI,LIU, JINPING,JIAO, GUOHUA

申请号：

PL08772950

公开号：

PL2163247T3

申请日:

2008.06.11

申请国别(地区):

PL

年份:

2015

代理人:

摘要：

The present invention discloses the use of naringenin and naringin as inhibitors for transforming growth factor-²1 signaling pathway, especially the use of naringenin and naringin as inhibitors for transforming growth factor-²1 signaling pathway in the manufacture of medicaments for treating or preventing fibrosis and cancers.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/